細胞増殖の世界市場予測:製品別(試薬、メディア、フローサイトメーター、遠心分離機、バイオリアクター)、細胞種類別(人間、動物)、用途別(再生医療・幹細胞研究、癌・細胞ベース研究)、エンドユーザー別、地域別

◆英語タイトル:Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025
◆商品コード:BT 2850
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年7月15日
◆ページ数:333
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は細胞増殖の世界市場が2020年149億ドルから2025年301億ドルまで、年平均15.1%成長すると見込んでいます。本調査レポートでは、細胞増殖の世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、製品別(消耗品、器具)分析、細胞種類別(ヒト細胞、動物細胞)分析、用途別(再生医療・幹細胞研究、癌・細胞ベース研究、その他)分析、エンドユーザー別(バイオテクノロジー&バイオ医薬品企業、研究機関、細胞銀行、その他)分析、地域別分析、競争状況、企業概要などを含めており、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・細胞増殖の世界市場規模:製品別(消耗品、器具)
・細胞増殖の世界市場規模:細胞種類別(ヒト細胞、動物細胞)
・細胞増殖の世界市場規模:用途別(再生医療・幹細胞研究、癌・細胞ベース研究、その他)
・細胞増殖の世界市場規模:エンドユーザー別(バイオテクノロジー&バイオ医薬品企業、研究機関、細胞銀行、その他)
・細胞増殖の世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

“Increasing incidence of chronic diseases, and government investments for cell-based research are set to drive the cell expansion market.’’
The global cell expansion market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%. Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

“By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market”
The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.

“By cell type, the human cells segment accounted for the largest share of the cell expansion market”
Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

“Asia Pacific: The fastest-growing region in the cell expansion market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.

“North America: the largest share of the cell expansion market”
North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
• By Company Type– Tier 1- 70%, Tier 2- 20% and Tier 3 – 10%
• By Designation— C level Executives- 30%, Directors- 20%, Others – 50%
• By Region— North America – 35%, Europe – 24%, APAC – 25%, RoW- 16%

The cell expansion market is dominated by a few globally established players such as Thermo Fisher Scientific, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Corning, Inc. (US), Merck KGaA (Germany), Sartorius Stedim Biotech (France), Getinge AB (Sweden) Terumo Corporation (Japan), Miltenyi Biotec (Germany), PromoCell GmbH (Germany), Takara Bio Inc. (Japan), Solida Biotech GmBH (Germany), HiMedia Laboratories (India), Getinge AB, REPROCELL Inc. (Japan), Kohjin-Bio (Japan), Pierre Guérin (France), Cellexus Ltd.(UK), Eppendorf AG (Germany), CellGenix GmbH (Germany), iXCells Biotechnologies (US), Neuromics (US), Celltainer Biotech B.V. (Netherlands), and G&G Technologies (US).

Research Coverage:
The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users).
The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the cell expansion market and provides them information on key market drivers, restraints, challenges, and opportunities.

【レポートの目次】



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[細胞増殖の世界市場予測:製品別(試薬、メディア、フローサイトメーター、遠心分離機、バイオリアクター)、細胞種類別(人間、動物)、用途別(再生医療・幹細胞研究、癌・細胞ベース研究)、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆